An immunosuppressed Syrian golden hamster model for SARS-CoV infection

Abstract Several small animal models have been developed for the study of severe acute respiratory syndrome coronavirus (SARS-CoV) replication and pathogenesis. Syrian golden hamsters are among the best small animal models, though little clinical illness and no mortality are observed after virus infection. Cyclophosphamide was used to immunosuppress hamsters leading to a prolonged disease course and higher mortality after SARS-CoV infection. In addition, there was a significant weight loss, expanded tissue tropism, and increased viral pathology in the lung, heart, kidney, and nasal turbinate tissues. Infection with recombinant SARS-CoV viruses bearing disruptions in the gene 7 coding region showed no significant change in replication kinetics, tissue tropism, morbidity, or mortality suggesting that the ORF7a (7a) and ORF7b (7b) proteins are not required for virus replication in immunosuppressed hamsters. This modified hamster model may provide a useful tool for SARS-CoV pathogenesis studies, evaluation of antiviral therapy, and analysis of additional SARS-CoV mutants.

[1]  Shuyi Zhang,et al.  Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. , 2006, The Journal of general virology.

[2]  K. Robison,et al.  A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 , 2000, Circulation research.

[3]  D. Ho,et al.  Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals , 2005, Journal of medical virology.

[4]  Revised U.S. surveillance case definition for severe acute respiratory syndrome (SARS) and update on SARS cases--United States and worldwide, December 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[5]  T. Greenough,et al.  Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters , 2006, The Journal of infectious diseases.

[6]  Ralph S. Baric,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection of Human Ciliated Airway Epithelia: Role of Ciliated Cells in Viral Spread in the Conducting Airways of the Lungs , 2005, Journal of Virology.

[7]  J. Turk,et al.  Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity , 1974, Nature.

[8]  M. St. Claire,et al.  Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys , 2004, Virology.

[9]  Jonathan H. Epstein,et al.  Bats Are Natural Reservoirs of SARS-Like Coronaviruses , 2005, Science.

[10]  Y. Guan,et al.  Detection of SARS Coronavirus in Patients with Suspected SARS , 2004, Emerging infectious diseases.

[11]  Y. Guan,et al.  Detection of SARS Coronavirus in Patients with Severe Acute Respiratory Syndrome by Conventional and Real-Time Quantitative Reverse Transcription-PCR Assays , 2004, Clinical chemistry.

[12]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[13]  Bo Zhang,et al.  Multiple organ infection and the pathogenesis of SARS , 2005, The Journal of experimental medicine.

[14]  Kwok-Hung Chan,et al.  Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Z. Lang,et al.  A clinicopathological study of three cases of severe acute respiratory syndrome (SARS) , 2003, Pathology.

[16]  R. Chandra,et al.  Mechanisms of Host Defense , 1977 .

[17]  Jeng-Min Chiou,et al.  Neutralizing Antibody Response and SARS Severity , 2005, Emerging infectious diseases.

[18]  Nigel M. Hooper,et al.  A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.

[19]  J. Jarrell,et al.  Ovarian toxicity of cyclophosphamide alone and in combination with ovarian irradiation in the rat. , 1987, Cancer research.

[20]  R. Crystal,et al.  Macaque Model for Severe Acute Respiratory Syndrome , 2004, Journal of Virology.

[21]  R. Baric,et al.  Severe Acute Respiratory Syndrome Coronavirus Group-Specific Open Reading Frames Encode Nonessential Functions for Replication in Cell Cultures and Mice , 2005, Journal of Virology.

[22]  Michelle M. Packard,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor , 2006, Journal of Virology.

[23]  A. Pekosz,et al.  Severe Acute Respiratory Syndrome Coronavirus Gene 7 Products Contribute to Virus-Induced Apoptosis , 2007, Journal of Virology.

[24]  H. Guzmán,et al.  Effects of immunosuppression on West Nile virus infection in hamsters. , 2006, The American journal of tropical medicine and hygiene.

[25]  T. Slezak,et al.  Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome , 2006, PLoS medicine.

[26]  Z. Ikezawa,et al.  Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. , 2005, Journal of dermatological science.

[27]  Jiang Gu,et al.  Pathology and Pathogenesis of Severe Acute Respiratory Syndrome , 2007, The American Journal of Pathology.

[28]  R. Crystal,et al.  Resolution of Primary Severe Acute Respiratory Syndrome-Associated Coronavirus Infection Requires Stat1 , 2004, Journal of Virology.

[29]  V. Cheng,et al.  Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection , 2007, Clinical Microbiology Reviews.

[30]  S. Perlman,et al.  Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice , 2008, Virology.

[31]  C. Peters,et al.  Immunosuppression-induced susceptibility of inbred hamsters (Mesocricetus auratus) to lethal-disease by lymphocytic choriomeningitis virus infection , 2005, Archives of Virology.

[32]  A. Fauci,et al.  Suppression of human B lymphocyte function by cyclophosphamide. , 1982, Journal of immunology.

[33]  C. Leung,et al.  Epidemiologic linkage and public health implication of a cluster of severe acute respiratory syndrome in an extended family. , 2004, The Pediatric infectious disease journal.

[34]  T. Greenough,et al.  Pneumonitis and Multi-Organ System Disease in Common Marmosets (Callithrix jacchus) Infected with the Severe Acute Respiratory Syndrome-Associated Coronavirus , 2005, The American Journal of Pathology.

[35]  T. Kuiken,et al.  Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets , 2004, The Lancet.

[36]  R. Lockey,et al.  An immunocompromised BALB/c mouse model for respiratory syncytial virus infection , 2005, Virology Journal.

[37]  D. Smee,et al.  Progressive murine cytomegalovirus disease after termination of ganciclovir therapy in mice immunosuppressed by cyclophosphamide treatment. , 1991, The Journal of infectious diseases.

[38]  Ralph S. Baric,et al.  Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  David K. Meyerholz,et al.  Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.

[40]  Ralph Baric,et al.  A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice , 2007, PLoS pathogens.

[41]  Yonggang Liu,et al.  Civets Are Equally Susceptible to Experimental Infection by Two Different Severe Acute Respiratory Syndrome Coronavirus Isolates , 2005, Journal of Virology.

[42]  Andrew Pekosz,et al.  The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV Particles , 2006, Journal of Virology.

[43]  A. Fauci,et al.  Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. , 1987, The Journal of clinical investigation.

[44]  W. Travis,et al.  Analysis of deaths during the severe acute respiratory syndrome (SARS) epidemic in Singapore: challenges in determining a SARS diagnosis. , 2004, Archives of pathology & laboratory medicine.

[45]  Andrew Pekosz,et al.  Structure and Intracellular Targeting of the SARS-Coronavirus Orf7a Accessory Protein , 2005, Structure.

[46]  D. Smee,et al.  Inhibition of influenza virus infections in immunosuppressed mice with orally administered peramivir (BCX-1812). , 2003, Antiviral Research.

[47]  B. Mitchell,et al.  Immune transfer protects severely immunosuppressed mice from murine cytomegalovirus retinitis and reduces the viral load in ocular tissue. , 2000, The Journal of infectious diseases.

[48]  R. Baric,et al.  Animal models and vaccines for SARS-CoV infection , 2007, Virus Research.

[49]  S. Brody,et al.  Differentiated cultures of primary hamster tracheal airway epithelial cells , 2007, In Vitro Cellular & Developmental Biology - Animal.

[50]  W. Marasco,et al.  An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus , 2005, The Journal of pathology.

[51]  B. Murphy,et al.  Severe Acute Respiratory Syndrome Coronavirus Infection of Golden Syrian Hamsters , 2005, Journal of Virology.

[52]  J. Sagartz,et al.  Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model , 2008, Proceedings of the National Academy of Sciences.

[53]  G. Gao,et al.  Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[54]  Malik Peiris,et al.  Aetiology: Koch's postulates fulfilled for SARS virus , 2003, Nature.

[55]  K. Subbarao,et al.  Aged BALB/c Mice as a Model for Increased Severity of Severe Acute Respiratory Syndrome in Elderly Humans , 2005, Journal of Virology.

[56]  Xin Li,et al.  The clinical pathology of severe acute respiratory syndrome (SARS): a report from China , 2003, The Journal of pathology.

[57]  J. Bartlett.  Virology: SARS virus infection of cats and ferrets , 2004 .